AU2003245750A1 - Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator - Google Patents
Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulatorInfo
- Publication number
- AU2003245750A1 AU2003245750A1 AU2003245750A AU2003245750A AU2003245750A1 AU 2003245750 A1 AU2003245750 A1 AU 2003245750A1 AU 2003245750 A AU2003245750 A AU 2003245750A AU 2003245750 A AU2003245750 A AU 2003245750A AU 2003245750 A1 AU2003245750 A1 AU 2003245750A1
- Authority
- AU
- Australia
- Prior art keywords
- immunomodulator
- oxidised cellulose
- polyanhydroglucuronic acid
- microdispersed
- microdispersed oxidised
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35611402P | 2002-02-14 | 2002-02-14 | |
US60/356,114 | 2002-02-14 | ||
PCT/IE2003/000023 WO2003068245A1 (en) | 2002-02-14 | 2003-02-14 | Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003245750A1 true AU2003245750A1 (en) | 2003-09-04 |
Family
ID=27734608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003245750A Abandoned AU2003245750A1 (en) | 2002-02-14 | 2003-02-14 | Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003245750A1 (en) |
WO (1) | WO2003068245A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7763769B2 (en) | 2001-02-16 | 2010-07-27 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7700819B2 (en) | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
WO2007036920A2 (en) * | 2005-09-28 | 2007-04-05 | Alltracel Development Services Limited | Therapeutic use of polyanhydroglucronic acid |
WO2007123187A1 (en) * | 2006-04-20 | 2007-11-01 | Itoham Foods Inc. | Pharmaceutical composition for conformational disease |
AU2012275265B2 (en) | 2011-06-29 | 2017-05-04 | Covidien Lp | Dissolution of oxidized cellulose |
US9271937B2 (en) | 2012-05-31 | 2016-03-01 | Covidien Lp | Oxidized cellulose microspheres |
US9168227B2 (en) | 2012-05-31 | 2015-10-27 | Covidien Lp | Multi-encapsulated microspheres made with oxidized cellulose for in-situ reactions |
US9138489B2 (en) | 2012-05-31 | 2015-09-22 | Covidien Lp | Oxidized cellulose miczrospheres including visualization agents |
US9447196B2 (en) | 2012-06-28 | 2016-09-20 | Covidien Lp | Dissolution of oxidized cellulose and particle preparation by solvent and non-solvent precipitation |
US10040871B2 (en) | 2012-06-28 | 2018-08-07 | Covidien Lp | Medical devices based on oxidized cellulose |
US9447197B2 (en) | 2012-06-28 | 2016-09-20 | Covidien Lp | Dissolution of oxidized cellulose and particle preparation by dispersion and neutralization |
US9499636B2 (en) | 2012-06-28 | 2016-11-22 | Covidien Lp | Dissolution of oxidized cellulose and particle preparation by cross-linking with multivalent cations |
US10328095B2 (en) | 2013-03-15 | 2019-06-25 | Covidien Lp | Resorbable oxidized cellulose embolization microspheres |
US10413566B2 (en) | 2013-03-15 | 2019-09-17 | Covidien Lp | Thixotropic oxidized cellulose solutions and medical applications thereof |
US9782430B2 (en) | 2013-03-15 | 2017-10-10 | Covidien Lp | Resorbable oxidized cellulose embolization solution |
US10449152B2 (en) | 2014-09-26 | 2019-10-22 | Covidien Lp | Drug loaded microspheres for post-operative chronic pain |
CN115607508B (en) * | 2022-09-09 | 2024-03-15 | 杭州医学院 | Nasal administration preparation for preventing and treating pneumonia caused by influenza A virus and preparation method and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2337201B (en) * | 1997-01-30 | 2001-02-14 | Alpenstock Holdings Ltd | Haemostatic aerosol composition |
IE980056A1 (en) * | 1997-01-30 | 2000-02-09 | Alpenstock Holdings Ltd | Cellulose derivates |
EP1098654A1 (en) * | 1998-07-21 | 2001-05-16 | Alpenstock Holdings Limited | Antilipemic composition comprising a polysaccharide containing glucuronic acid |
-
2003
- 2003-02-14 WO PCT/IE2003/000023 patent/WO2003068245A1/en not_active Application Discontinuation
- 2003-02-14 AU AU2003245750A patent/AU2003245750A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003068245A1 (en) | 2003-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003245750A1 (en) | Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator | |
AU2003202259A1 (en) | Lipid compositions, production thereof and of esters | |
AU2003222083A1 (en) | Acid and ester compounds and methods of using the same | |
AU2003295336A1 (en) | Use of etodoclac to treat hyperplasia | |
AU2003230952A1 (en) | Treatment of mucositis | |
AU2002367007A1 (en) | Stabilisation of acid catalysts | |
AU2003205558A1 (en) | Thioibotenic acid and derivatives thereof | |
AU7958100A (en) | Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics | |
AU2003238605A1 (en) | Dynamic representations of processes | |
AU2002952155A0 (en) | Production of titania | |
AU2003289171A1 (en) | Cosmetic preparation containing glycerylamino acid derivative | |
AU2003290249A1 (en) | Purification of nanotubes | |
AU2003297597A1 (en) | Benzimidazoles and analogs thereof as antibacterials | |
AU2003266709A1 (en) | Method of coagulating poly-3-hydroxyalkanoic acid | |
EP1572117A3 (en) | Production of ubiquinones | |
AU2003297563A1 (en) | Production of ubiquinones | |
AU2003208926A1 (en) | Integration of at least two processes to re-use acid | |
AU2003260316A1 (en) | Regulation of human hepsin | |
AU2003235452A1 (en) | Use of hydroxyeicosatetraenoic acid compounds to treat dry mouth | |
AU2003299746A1 (en) | Total synthesis of daurichromenic acid | |
AU2003231527A1 (en) | Novel derivatives of carnosic acid | |
AU2003208900A1 (en) | L-carnitine for treatment of hearing loss | |
AU2003238034A1 (en) | Novel use of imidazotriazinones | |
IL166778A0 (en) | Derivatives of gl ycinergic r(+)-2-amino-3-hydroxypropanoic acid | |
AU2003289876A1 (en) | Cutaneous application of flupirtine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |